Abstract
A physiologically based pharmacokinetic model for diazepam disposition was developed in the rat, incorporating anatomical, physiological, and biochemical parameters, i.e., tissue volume, blood flow rate, serum free fraction, distribution of diazepam into red blood cells, drug metabolism and tissue-to-blood distribution ratio. The serum free fraction of diazepam was determined by equilibrium dialysis at 37°C and was constant over a wide concentration range. Partition of diazepam between plasma and erythrocytes was determined in vitroat 37°C, and the resultant blood-to-plasma concentration ratio was constant over a wide concentration range. The enzymatic parameters (Km, Vmax)of the eliminating organs, i.e., liver, kidney, and lung, previously determined using microsomes, were used for the prediction. The tissue-to-blood distribution ratios inferred by inspection of the data when pseudoequilibrium is reached after i.v. bolus injection of 1.2 mg/kg diazepam were corrected according to the method of Chen and Gross. Predicted diazepam concentration time-course profiles in plasma and various organs or tissues, using an 11-compartmental model, were compared with those observed. Prediction was successful in all compartments including brain, the target organ of diazepam. Scale-up of the disposition kinetics of diazepam from rat to man was also successful.
Similar content being viewed by others
References
R. L. Dedrick and K. B. Bischoff. Pharmacokinetics in application of the artificial kidney.Chem. Eng. Prog. Symp. Ser. 64:32–44 (1968).
H. S. G. Chen and J. F. Gross. Physiologically based pharmacokinetic models for anticancer drugs (general review).Cancer Chemother. Pharmacol. 2:85–94 (1979).
K. J. Himmelstein and R. J. Lutz. A review of the applications of physiologically based pharmacokinetic modeling.J. Pharmacokin. Biopharm. 7:127–145 (1979).
R. L. Dedrick. Animal scale-up.J. Pharmacokin. Biopharm. 1:435–461 (1973).
K. B. Bischoff and R. L. Dedrick. Thiopental pharmacokinetics.J. Pharm. Sci. 57:1347–1357 (1968).
K. B. Bischoff, R. L. Dedrick, D. S. Zaharko, and J. A. Longstreth. Methotrexate pharmacokinetics.J. Pharm. Sci. 60:1128–1133 (1971).
R. L. Dedrick, D. D. Forrester, J. N. Cannon, S. M. El Dareer, and L. B. Mallett. Pharmacokinetics of 1-β-D-arabinofuranosylcytosine (Ara-C) deamination in several species.Biochem. Pharmacol. 22:2405–2417 (1973).
N. Benowitz, R. P. Forsyth, K. L. Melmon, and M. Rowland. Lidocaine disposition kinetics in monkey and man I: Prediction by a perfusion model.Clin. Pharmacol. Ther. 16:87–98 (1974).
B. Montandon, R. J. Roberts, and L. J. Fischer. Computer simulation of sulfobromophthalein kinetics in the rat using flow-limited models with extrapolation to man.J. Pharmacokin. Biopharm. 3:277–290 (1975).
L. I. Harrison and M. Gibaldi. Physiologically based pharmacokinetic model for digoxin disposition in dogs and its preliminary application to humans.J. Pharm. Sci. 66:1679–1683 (1977).
U. Klotz, K. H. Antonin, and P. R. Bieck. Pharmacokinetics and plasma protein binding of diazepam in man, dog, rabbit, guinea pig and rat.J. Pharmacol. Exp. Ther. 199:67–73 (1976).
Y. Sugiyama, T. Iga, S. Awazu, and M. Hanano. Multiplicity of sulfobromophthalein-binding proteins in Y-fraction from rat liver.J. Pharm. Dyn. 2:193–204 (1979).
Y. Igari, Y. Sugiyama, Y. Sawada, T. Iga, and M. Hanano. Tissue distribution of14C-diazepam and its metabolities in the rat.Drug. Metab. Dispos. 10:676–679 (1982).
T. Inaba, E. Tsutsumi, W. A. Mahon, and W. Kalow. Biliary excretion of diazepam in the rat.Drug. Metab. Dispos. 2:429–432 (1974).
E. Arnold. A simple method for determining diazepam and its major metabolites in biological fluids: application in bioavailability studies.Acta Pharmacol. Toxicol. 36:335–352 (1975).
Y. Sasaki and N. Wagner. Measurement of the distribution of cardiac output in unanaes-thetized rats.J. Appl. Physiol. 30:879–884 (1968).
R. L. Dedrick, D. S. Zaharko, and R. J. Lutz. Transport and binding of methotrexatein vivo.J. Pharm. Sci. 62:882–890 (1973).
R. J. Lutz, R. L. Dedrick, H.B. Matthews, T. E. Eling, and M. W. Anderson. A preliminary pharmocokinetic model for several chlorinated biphenyls in the rat.Drug. Metab. Dispos. 5:386–396 (1977).
W. S. Spector (ed.).Handbook of Biological Data, W. B. Saunders, Philadelphia, 1956, pp. 163–283.
W. W. Mapleson. An electronic analogue for uptake and exchange of inert gases and other agents.J. Appl. Physiol. 18:197–204 (1963).
P. L. Altman and D. S. Dittmer (eds.).Biology Data Book, 2nd ed. Vol. 3, Bethesda, 1974, pp. 1571–1750.
Y. Igari, Y. Sugiyama, Y. Sawada, T. Iga, and M. Hanano.In vitro andin vivo assessment of hepatic and extrahepatic metabolism of diazepam in the rat.J. Pharm. Sci., in press.
C. L. Litterst, E. G. Mimnaugh, R. L. Reagan, and T. E. Gram. Comparison ofin vitro drug metabolism by lung, liver and kidney of several common laboratory species.Drug. Metab. Dispos. 3:259–265 (1975).
H. S. G. Chen and J. F. Gross. Estimation of tissue to plasma partition coefficients used in physiological pharmacokinetic models.J. Pharmacokin. Biopharm. 7:117–125 (1979).
D. R. Abernethy and D. J. Greenblatt. Effects of desmethyl diazepam on diazepam kinetics: a study of effects of a metabolite on parent drug disposition.Clin. Pharmacol. Ther. 29:757–761 (1981).
U. Klotz and I. Reimann. Clearance of diazepam can be impaired by its major metabolite desmethyl diazepam.Eur. J. Clin. Pharmacol. 21:161–163 (1981).
U. Klotz, G. R. Avant, A. Hoyumpa, S. Schenker, and G. R. Wilkinson. The effects of age and liver disease on the disposition and elimination of diazepam in adult man.J. Clin. Invest. 55:347–359 (1975).
R. L. Dedrick, D. D. Forrester, and D. H. W. Ho.In vitro-in vivo correlation of drug metabolism—deamination of 1-β-D-arabinofuranosylcytosine.Biochem. Pharmacol. 21:1–16 (1972).
J. M. Collins, R. L. Dedrick, F. G. King, J. L. Speyer, and C. E. Myers. Nonlinear pharmacokinetic models for 5-fluorouracil in man: intravenous and intraperitonial routes.Clin. Pharmacol. Ther. 28:235–246 (1980).
M. K. Cassidy and J. B. Houston.In vivo assessment of extrahepatic conjugative metabolism in first-pass effects using the model compound phenol.J. Pharm. Pharmacol. 32:57–59 (1980).
A. Rane, G. R. Wilkinson, and D. G. Shand. Prediction of hepatic extraction ratio fromin vitro measurement of intrinsic clearance.J. Pharmacol. Exp. Ther. 200:420–424 (1977).
J. H. Lin, M. Hayashi, S. Awazu, and M. Hanano. Correlation betweenin vitro andin vivo drug metabolism rate: oxidation of ethoxybenzamide in rat.J. Pharmacokin. Biopharm. 6:327–337 (1978).
B. R. Smith and J. R. Bend. Prediction of pulmonary benzo(a)pyren 4,5-oxide clearance: a pharmacokinetic analysis of epoxide-metabolizing enzymes in rabbit lung.J. Pharmacol. Exp. Ther. 214:478–482 (1980).
H. Boxenbaum. Interspecies variation in liver weight, hepatic blood flow and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.J. Pharmacokin. Biopharm. 8:165–176 (1980).
J. H. Lin, Y. Sugiyama, S. Awazu, and M. Hanano. Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtainedin vitro as well as on physiological data.J. Pharmacokin. Biopharm. 10:649–661 (1982).
S. H. Curry. Relation between binding to plasma protein, apparent volume of distribution, and rate constants of disposition and elimination for chlorpromazine in three species.J. Pharm. Pharmacol. 24:818–819 (1972).
G. H. Evans. The disposition of propranolol. III: Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.J. Pharmacol. Exp. Ther. 186:114–122 (1973).
J. H. Lin, Y. Sugiyama, S. Awazu, and M. Hanano. Kinetic studies on the deethylation of ethoxybenzamide.Biochem. Pharmacol. 29:2825–2830 (1980).
Author information
Authors and Affiliations
Additional information
This study was supported by a grant-in-aid for scientific research provided by the Ministry of Education, Science and Culture of Japan. A portion of the paper appeared in a dissertation submitted by Y. Igari to the Graduate Division, University of Tokyo, in partial fulfillment of the requirement for the Ph.D. degree.
Rights and permissions
About this article
Cite this article
Igari, Y., Sugiyama, Y., Sawada, Y. et al. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model. Journal of Pharmacokinetics and Biopharmaceutics 11, 577–593 (1983). https://doi.org/10.1007/BF01059058
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01059058